Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Flail Chest-II

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Pneumothorax-II

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

EMBER-Lung: Electronic Medical Record Boosting Molecular Testing in Early-Stage Non-Small Cell Lung Cancer.

JCO precision oncology·2026

Same author

Treatment Attrition From Surgery to Adjuvant Therapy in Stage IIB and IIIA Lung Adenocarcinoma: A National Cancer Database Analysis.

Clinical lung cancer·2026

Same author

Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma.

Cancers·2025

Same author

Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy.

American journal of clinical oncology·2025

Same author

Esophageal-Pericardial and Esophageal-Atrial Fistulae.

Thoracic surgery clinics·2024

Same author

A pH-Activatable Nanoprobe Labels Diverse Histologic Subtypes of Human Lung Cancer During Resection.

Molecular imaging and biology·2023

Search research articles

Related Experiment Video

Updated: May 27, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Chest wall sarcomas and induction therapy.

John C Kucharczuk¹

¹Division of Thoracic Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. john.kucharczuk@uphs.upenn.edu

Thoracic Surgery Clinics

|November 24, 2011

Summary

Chest wall sarcomas require specialized multidisciplinary care. Complete surgical resection is crucial for patient survival, but optimal adjuvant therapy remains unclear.

Area of Science:

Oncology
Surgical Oncology
Thoracic Surgery

Background:

Chest wall sarcomas are rare malignancies with limited established treatment guidelines.
Optimal management strategies, particularly regarding neoadjuvant or adjuvant therapies, are not well-defined.
Extrapolation of extremity sarcoma guidelines to chest wall tumors is uncertain.

Purpose of the Study:

To review the current understanding of chest wall sarcoma management.
To highlight the importance of a multidisciplinary approach and complete surgical resection.
To identify gaps in evidence regarding preoperative adjuvant therapy for chest wall sarcomas.

Main Methods:

Review of existing literature and clinical guidelines for sarcoma treatment.
Case-based analysis of treatment decisions for chest wall sarcomas.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Related Experiment Videos

Last Updated: May 27, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Comparison of management strategies for chest wall versus extremity sarcomas.

Main Results:

A formalized multidisciplinary treatment plan in a specialized center is associated with better patient outcomes.
Wide, complete (R0) resection is the most critical factor for local control and long-term survival.
Evidence supporting the benefit of preoperative adjuvant therapy for chest wall sarcomas is lacking, necessitating individualized treatment decisions.

Conclusions:

Chest wall sarcoma management necessitates a specialized, multidisciplinary approach.
Complete surgical resection is paramount for achieving optimal patient outcomes.
Further research is needed to establish clear guidelines for adjuvant therapy in chest wall sarcomas.